Colin Hammond

Title: Colin Hammond: Innovator in Histone Reader Domain Research

Introduction

Colin Hammond is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of molecular biology, particularly in the area of histone reader domains. His innovative work has led to the development of a patent that addresses critical mechanisms in gene regulation.

Latest Patents

Colin Hammond holds a patent titled "Small molecules blocking histone reader domains." This invention relates to small molecules that interfere with the conformational space of the TONSL ARD occupied by the histone H4 tail. These small molecules target the binding pocket of TONSL, encompassing the H4 residues K12-R23, and act by preventing or disrupting the binding of the H4 tail K12-R23 with the TONSL ARD via direct competition or allosteric disruption of the binding pocket. He has 1 patent to his name.

Career Highlights

Throughout his career, Colin has worked with prestigious institutions, including the University of Copenhagen and Memorial Sloan Kettering Cancer Center. His research has focused on understanding the molecular interactions that govern gene expression and regulation.

Collaborations

Colin has collaborated with esteemed colleagues such as Anja Groth and Giulia Saredi. Their combined expertise has contributed to advancing research in the field of histone modifications and their implications in cancer biology.

Conclusion

Colin Hammond's innovative work in developing small molecules that block histone reader domains showcases his commitment to advancing scientific knowledge. His contributions are vital for understanding gene regulation and have the potential to impact therapeutic strategies in cancer treatment.